Artificial intelligence continues to transform diagnostics and therapeutics across biomedical fields. Studies demonstrate AI’s capacity to enhance single-cell analysis via hypersonic levitation, improve ECG-based amyloidosis detection, and optimize electronic health record phenotyping. Oncology research leverages AI to classify circulating tumor cells precisely and improve radiation oncology outcomes. Furthermore, AI systems autonomously prescribe drugs to prevent severe graft-versus-host disease. These technologies exhibit accelerated accuracy, efficiency, and potential to personalize treatments, underscoring AI's expanding role in biomedicine.